PL3312181T3 - Związek imidazodiazepiny - Google Patents
Związek imidazodiazepinyInfo
- Publication number
- PL3312181T3 PL3312181T3 PL16811742T PL16811742T PL3312181T3 PL 3312181 T3 PL3312181 T3 PL 3312181T3 PL 16811742 T PL16811742 T PL 16811742T PL 16811742 T PL16811742 T PL 16811742T PL 3312181 T3 PL3312181 T3 PL 3312181T3
- Authority
- PL
- Poland
- Prior art keywords
- imidazodiazepine
- compound
- imidazodiazepine compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015123478 | 2015-06-19 | ||
| EP16811742.2A EP3312181B1 (en) | 2015-06-19 | 2016-06-17 | Imidazodiazepine compound |
| PCT/JP2016/068080 WO2016204268A1 (ja) | 2015-06-19 | 2016-06-17 | イミダゾジアゼピン化合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3312181T3 true PL3312181T3 (pl) | 2020-01-31 |
Family
ID=57546103
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16811742T PL3312181T3 (pl) | 2015-06-19 | 2016-06-17 | Związek imidazodiazepiny |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US10426784B2 (pl) |
| EP (1) | EP3312181B1 (pl) |
| JP (1) | JP6658753B2 (pl) |
| KR (1) | KR102591169B1 (pl) |
| CN (2) | CN111205292B (pl) |
| AR (1) | AR105025A1 (pl) |
| AU (1) | AU2016279518B2 (pl) |
| CA (1) | CA2989982C (pl) |
| CO (1) | CO2018000431A2 (pl) |
| CY (1) | CY1122232T1 (pl) |
| DK (1) | DK3312181T3 (pl) |
| ES (1) | ES2751913T3 (pl) |
| HR (1) | HRP20191961T1 (pl) |
| HU (1) | HUE047430T2 (pl) |
| IL (1) | IL256252B (pl) |
| LT (1) | LT3312181T (pl) |
| MX (1) | MX2017016690A (pl) |
| MY (1) | MY197499A (pl) |
| PH (1) | PH12017502253A1 (pl) |
| PL (1) | PL3312181T3 (pl) |
| PT (1) | PT3312181T (pl) |
| RS (1) | RS59497B1 (pl) |
| RU (1) | RU2712968C2 (pl) |
| SG (1) | SG11201710345VA (pl) |
| SI (1) | SI3312181T1 (pl) |
| TW (1) | TWI697496B (pl) |
| UA (1) | UA120006C2 (pl) |
| WO (1) | WO2016204268A1 (pl) |
| ZA (1) | ZA201708566B (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI725408B (zh) | 2018-04-20 | 2021-04-21 | 美商美國禮來大藥廠 | 多巴胺d1受體正向異位調節劑 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7067507B2 (en) * | 2001-06-12 | 2006-06-27 | Pharmacia & Upjohn Company | Macrocycles useful in the treatment of Alzheimer's disease |
| WO2003077847A2 (en) | 2002-03-12 | 2003-09-25 | Merck & Co., Inc. | Substituted amides |
| AU2003244160A1 (en) * | 2002-06-25 | 2004-01-06 | Sumitomo Pharmaceuticals Co., Ltd. | Novel benzoxazolinone derivative |
| EP1718611A4 (en) * | 2004-02-13 | 2009-09-23 | Harvard College | 3-3-DI-SUBSTITUTED OXINDOLES AS INHIBITORS OF INITIATION OF TRANSLATION |
| CN1922141A (zh) * | 2004-02-23 | 2007-02-28 | 大日本住友制药株式会社 | 新的杂环化合物 |
| ES2332597T3 (es) | 2004-05-27 | 2010-02-09 | Ucb Pharma S.A. | Derivados de benzoxazolona, procedimientos para su preparacion y su uso. |
| CL2007002097A1 (es) | 2006-07-20 | 2008-01-18 | Smithkline Beecham Corp | Compuestos derivados de pirrolidina o morfolina antagonistas de urotensina ii; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar insuficiencia cardiaca congestiva, insuficiencia cardiaca isquemica, angina, isquemia del miocardio, vejiga hiperactiva, asma y/o copd, entre otras. |
| PE20081229A1 (es) * | 2006-12-01 | 2008-08-28 | Merck & Co Inc | Antagonistas de receptor de orexina de diazepam sustituido |
| UY33463A (es) | 2010-06-24 | 2012-01-31 | Takeda Pharmaceutical | Compuestos heterocíclicos fusionados |
| AR095883A1 (es) | 2013-04-18 | 2015-11-18 | Astellas Pharma Inc | Compuestos de acetamida heterocíclica |
-
2016
- 2016-06-16 AR ARP160101804A patent/AR105025A1/es unknown
- 2016-06-17 RS RS20191427A patent/RS59497B1/sr unknown
- 2016-06-17 WO PCT/JP2016/068080 patent/WO2016204268A1/ja active Application Filing
- 2016-06-17 PT PT168117422T patent/PT3312181T/pt unknown
- 2016-06-17 KR KR1020177036276A patent/KR102591169B1/ko active IP Right Grant
- 2016-06-17 US US15/737,564 patent/US10426784B2/en active Active
- 2016-06-17 SG SG11201710345VA patent/SG11201710345VA/en unknown
- 2016-06-17 PL PL16811742T patent/PL3312181T3/pl unknown
- 2016-06-17 SI SI201630411T patent/SI3312181T1/sl unknown
- 2016-06-17 TW TW105119205A patent/TWI697496B/zh not_active IP Right Cessation
- 2016-06-17 CA CA2989982A patent/CA2989982C/en active Active
- 2016-06-17 EP EP16811742.2A patent/EP3312181B1/en active Active
- 2016-06-17 AU AU2016279518A patent/AU2016279518B2/en active Active
- 2016-06-17 MX MX2017016690A patent/MX2017016690A/es active IP Right Grant
- 2016-06-17 RU RU2018101861A patent/RU2712968C2/ru active
- 2016-06-17 UA UAA201800508A patent/UA120006C2/uk unknown
- 2016-06-17 ES ES16811742T patent/ES2751913T3/es active Active
- 2016-06-17 CN CN202010083916.3A patent/CN111205292B/zh active Active
- 2016-06-17 JP JP2017524854A patent/JP6658753B2/ja active Active
- 2016-06-17 LT LTEP16811742.2T patent/LT3312181T/lt unknown
- 2016-06-17 CN CN201680034335.2A patent/CN107635996B/zh active Active
- 2016-06-17 MY MYPI2017704807A patent/MY197499A/en unknown
- 2016-06-17 HU HUE16811742A patent/HUE047430T2/hu unknown
- 2016-06-17 DK DK16811742T patent/DK3312181T3/da active
-
2017
- 2017-12-11 PH PH12017502253A patent/PH12017502253A1/en unknown
- 2017-12-11 IL IL256252A patent/IL256252B/en active IP Right Grant
- 2017-12-15 ZA ZA2017/08566A patent/ZA201708566B/en unknown
-
2018
- 2018-01-17 CO CONC2018/0000431A patent/CO2018000431A2/es unknown
-
2019
- 2019-10-16 CY CY20191101083T patent/CY1122232T1/el unknown
- 2019-10-30 HR HRP20191961TT patent/HRP20191961T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201510019D0 (en) | Compounds | |
| GB201514754D0 (en) | Compounds | |
| GB201514751D0 (en) | Compounds | |
| HK1255832A1 (zh) | 吡喃並二吡啶化合物 | |
| GB201508747D0 (en) | Compounds | |
| GB201518365D0 (en) | Compounds | |
| GB201521524D0 (en) | Compound | |
| GB201510493D0 (en) | Compounds | |
| ZA201708566B (en) | Imidazodiazepine compound | |
| GB201518950D0 (en) | Compound | |
| GB201508857D0 (en) | Compounds | |
| GB201503926D0 (en) | Compounds | |
| GB201501115D0 (en) | Compounds | |
| HK1251574A1 (zh) | 四氫噁庚英吡啶化合物 | |
| GB201520391D0 (en) | Compound | |
| GB201520393D0 (en) | Compound | |
| GB201519549D0 (en) | Compounds | |
| GB201519212D0 (en) | Compounds | |
| GB201519213D0 (en) | Compounds | |
| GB201516059D0 (en) | Compounds | |
| GB201512279D0 (en) | Compounds | |
| GB201511387D0 (en) | Compounds | |
| GB201511064D0 (en) | Compounds | |
| GB201510910D0 (en) | Compounds | |
| GB201510760D0 (en) | Compounds |